Adoption of rimegepant in Denmark: a register-based study on uptake, prescribing patterns and initiator characteristics
Abstract Background Rimegepant, an oral calcitonin gene-related peptide (CGRP) receptor antagonist, is the first drug within its class approved for both acute and preventive treatment of migraine. This study examines its uptake in Denmark. Methods Using nationwide healthcare registry data, we analyz...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | The Journal of Headache and Pain |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10194-025-02028-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|